Moreover, increasing evidence has shown that UBE2T is involved in the carcinogenesis of different types of tumors, including lung cancer [11], gastric cancer [12], hepatocellular carcinoma [13], nasopharyngeal [14], osteosarcoma [15], and prostate cancer [16]. Here, UBE2T is linked to prostate carcinoma.